# EDA2R

## Overview
The EDA2R gene encodes the ectodysplasin A2 receptor, a transmembrane receptor that is part of the tumor necrosis factor receptor (TNFR) superfamily. This receptor plays a crucial role in mediating cell signaling pathways that are essential for the development and maintenance of ectodermal tissues, including skin, hair, and teeth. The protein encoded by EDA2R is activated through its interaction with the ligand ectodysplasin A2 (EDA-A2), which triggers downstream signaling cascades such as the NF-κB and JNK pathways. These pathways are involved in regulating apoptosis, cell proliferation, and differentiation, thereby influencing tissue morphogenesis and homeostasis (Cai2021Ectodysplasin; Yang2022Ectodysplasin). EDA2R's functional significance extends to various physiological and pathological contexts, including hair follicle cycling, metabolic disorders, and cancer, highlighting its potential as a therapeutic target (Kwack2019EctodysplasinA2; Lan2020EDA2R).

## Function
The EDA2R gene encodes the ectodysplasin A2 receptor, a member of the tumor necrosis factor receptor (TNFR) superfamily. This receptor is primarily involved in cell signaling pathways that regulate apoptosis, cell proliferation, and differentiation, contributing to the development and homeostasis of ectodermal tissues such as skin, hair, and teeth (Cai2021Ectodysplasin; Yang2022Ectodysplasin). EDA2R is activated by binding to its ligand, EDA-A2, which triggers the NF-κB and JNK signaling pathways. This activation leads to the recruitment of TRAF6 and the phosphorylation of IκB kinase (IKK), facilitating the translocation of NF-κB transcription factors into the nucleus (Cai2021Ectodysplasin).

In hair follicles, EDA2R is expressed in the outer root sheath (ORS) and dermal papilla (DP) cells, with its expression peaking during the late anagen phase of the hair growth cycle. This suggests a role in regulating hair cycle progression and apoptosis, potentially influencing conditions like androgenetic alopecia (Kwack2019EctodysplasinA2). EDA2R's involvement in these pathways highlights its significance in maintaining normal tissue morphogenesis and function.

## Clinical Significance
The EDA2R gene, also known as the ectodysplasin A2 receptor, is implicated in several diseases and conditions due to mutations, altered expression levels, or disrupted interactions. In diabetic nephropathy (DN), EDA2R expression is significantly increased in the kidneys of diabetic patients and mice, contributing to podocyte injury. This upregulation is associated with increased reactive oxygen species (ROS) production, apoptosis, and dedifferentiation of podocytes, which are critical factors in the progression of DN (Lan2020EDA2R). Silencing EDA2R in experimental models has been shown to reduce these harmful effects, suggesting its potential as a therapeutic target for DN (Lan2020EDA2R).

EDA2R is also involved in metabolic disorders. It is upregulated in conditions like non-alcoholic fatty liver disease (NAFLD) and insulin resistance, where it affects glucose and lipid metabolism. EDA2R's interaction with EDA-A2, a variant of Ectodysplasin A, is linked to metabolic dysfunctions, including obesity and type 2 diabetes mellitus (Cai2021Ectodysplasin).

In cancer, particularly colorectal cancer, EDA2R (also known as XEDAR) acts as a tumor suppressor. Its expression is often reduced due to p53 mutations or promoter hypermethylation, leading to enhanced cell adhesion and resistance to apoptosis, which contribute to tumor progression (Tanikawa2009XEDAR).

## Interactions
EDA2R, or ectodysplasin A2 receptor, is known for its interactions with ectodysplasin A2 (EDA-A2), a ligand of the tumor necrosis factor (TNF) family. This interaction is crucial for activating several signaling pathways, including the NF-κB and JNK pathways. EDA2R, upon binding with EDA-A2, recruits TRAF6 to the EDA-A2/EDA2R complex, which is essential for the activation of the IκB kinase (IKK) complex and the subsequent translocation of NF-κB transcription factors into the nucleus (Cai2021Ectodysplasin).

EDA2R is also involved in the regulation of apoptosis in various cell types, including hair follicle cells. EDA-A2 binding to EDA2R induces apoptosis in outer root sheath (ORS) and dermal papilla (DP) cells, which is mediated through the activation of apoptotic markers such as cleaved caspase-3 and Bax, while reducing the expression of the anti-apoptotic protein Bcl-2 (Kwack2019EctodysplasinA2).

In the context of myocardial ischemia/reperfusion (I/R) injury, EDA2R knockdown has been shown to inhibit the activation of the NF-κB signaling pathway, thereby reducing cardiomyocyte apoptosis and oxidative stress, highlighting its role in stress and inflammatory responses (GUAN2024EDA2R).


## References


[1. (Tanikawa2009XEDAR) C Tanikawa, Y Furukawa, N Yoshida, H Arakawa, Y Nakamura, and K Matsuda. Xedar as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway. Oncogene, 28(34):3081–3092, June 2009. URL: http://dx.doi.org/10.1038/onc.2009.154, doi:10.1038/onc.2009.154. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2009.154)

[2. (Lan2020EDA2R) Xiqian Lan, Vinod Kumar, Alok Jha, Rukhsana Aslam, Haichao Wang, Kehong Chen, Yueming Yu, Weimei He, Feilan Chen, Huairong Luo, Ashwani Malhotra, and Pravin C. Singhal. Eda2r mediates podocyte injury in high glucose milieu. Biochimie, 174:74–83, July 2020. URL: http://dx.doi.org/10.1016/j.biochi.2020.04.003, doi:10.1016/j.biochi.2020.04.003. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2020.04.003)

[3. (Kwack2019EctodysplasinA2) Mi Hee Kwack, Jung Chul Kim, and Moon Kyu Kim. Ectodysplasin-a2 induces apoptosis in cultured human hair follicle cells and promotes regression of hair follicles in mice. Biochemical and Biophysical Research Communications, 520(2):428–433, December 2019. URL: http://dx.doi.org/10.1016/j.bbrc.2019.10.031, doi:10.1016/j.bbrc.2019.10.031. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2019.10.031)

[4. (Cai2021Ectodysplasin) Zhensheng Cai, Xia Deng, Jue Jia, Dong Wang, and Guoyue Yuan. Ectodysplasin a/ectodysplasin a receptor system and their roles in multiple diseases. Frontiers in Physiology, December 2021. URL: http://dx.doi.org/10.3389/fphys.2021.788411, doi:10.3389/fphys.2021.788411. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2021.788411)

[5. (GUAN2024EDA2R) Zhi-Hui GUAN, Di YANG, Yi WANG, Jia-Bin MA, and Guo-Nian WANG. Eda2r knockdown alleviates myocardial ischemia/reperfusion injury through inhibiting the activation of the nf-κb signaling pathway. Experimental Animals, 2024. URL: http://dx.doi.org/10.1538/expanim.24-0020, doi:10.1538/expanim.24-0020. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1538/expanim.24-0020)

[6. (Yang2022Ectodysplasin) Ruihan Yang, Yilan Mei, Yuhan Jiang, Huiling Li, Ruixi Zhao, Jian Sima, and Yuyuan Yao. Ectodysplasin a (eda) signaling: from skin appendage to multiple diseases. International Journal of Molecular Sciences, 23(16):8911, August 2022. URL: http://dx.doi.org/10.3390/ijms23168911, doi:10.3390/ijms23168911. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23168911)